Medico Remedies Ltd
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FOB value of exports Rs crores ・Standalone data |
|
|||||||||||
| Number of manufacturing units count ・Standalone data |
||||||||||||
| Number of permanent employees count ・Standalone data |
||||||||||||
| Number of products count ・Standalone data |
||||||||||||
| Top 5 customers concentration % ・Standalone data |
||||||||||||
| Installed capacity for capsules million units per month ・Standalone data |
||||||||||||
| Installed capacity for dry syrups MT per month ・Standalone data |
||||||||||||
| Installed capacity for tablets million units per month ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Clarification On Price Movement
- Company says share price movement is market-driven; no pending disclosures.
-
Financial Results For The Quarter Ended On 30Th June, 2026
- Board approved Q1 FY27 results, reappointed two WTDs, raised MD remuneration, and issued 32nd AGM notice.
-
Board Meeting Intimation for Intimation Of Board Meeting.
- Board meeting on 13 Aug 2026 to approve Q1 FY27 unaudited results.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
- Medico Remedies won USD 1.406 million government supply order from PROMESE/CAL, Dominican Republic, to be completed in 3 months.
-
Clarification sought from Medico Remedies Ltd
- Exchange has sought clarification from Medico Remedies Ltd on August 3, 2026 with reference to significant movement in price, in order to ensure that investors …
Business Overview:[1][2]
MRL is a pharmaceutical formulation manufacturing and marketing company with focus on antibiotic, anti-infective, beta-lactam penicillin, cephalosporin, anti fungal, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins & supplements, hematinic and other drugs viz. NSAIDS, antihistaminic, anti-diabetics, cardiovascular drugs, antipyretic, analgesic, diuretics, anti-epileptics, antidepressants, antipsychotics, combination drug kits, dry syrups, ointments and cream & gel for various therapeutic segments